Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Losartan on Cephalexin
NCT07300670Phase 1Completed
- Start
- Mar 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of losartan and cefalexin in hypertension (HTN) and bacterial infection (6 arms). Primary endpoint: Plasma concentrations and pharmacokinetic parameters of cephalexin up to 8 hours. Started Mar 2026; status: completed.
02
Drugs
losartancefalexin
03
Conditions
hypertension (HTN)bacterial infection
Beyond the preview
Go deeper on NCT07300670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07300670.